Perampanel and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Perampanel (perampanel), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Clobazam, and have Epilepsy.

The phase IV clinical study analyzes which people have Overdose when taking Perampanel. It is created by eHealthMe based on reports of 2,473 people who have side effects when taking Perampanel from the FDA, and is updated regularly.

What is Perampanel?

Perampanel has active ingredients of perampanel. eHealthMe is studying from 2,474 Perampanel users. Check the latest studies of Perampanel.

What is Overdose?

Overdose is found to be associated with 2,222 drugs and 2,471 conditions by eHealthMe. Check the latest studies of Overdose.

On Jul, 10, 2026

2,473 people reported to have side effects when taking Perampanel.
Among them, 57 people (2.3%) have Overdose.

Among these 57 people:

How long have people been on Perampanel when they have Overdose? *

What is the gender of people who have Overdose when taking Perampanel? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Overdose when taking Perampanel? *

What are other drugs people take besides Perampanel? *

What are other side effects people have besides Overdose? *

Dizziness: 15 people, 26.32%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 15 people, 26.32%
Fall: 14 people, 24.56%
Multiple-Drug Resistance: 10 people, 17.54%
Movement - Uncoordinated: 9 people, 15.79%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 9 people, 15.79%
Subdural Haematoma (blood collects between the skull and the surface of the brain): 9 people, 15.79%
Skull Fracture: 9 people, 15.79%
Weight Increased: 7 people, 12.28%
Gingival Disorder (gum disease): 7 people, 12.28%

What are the existing conditions these people have? *

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 17 people, 29.82%
Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 7 people, 12.28%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 12.28%
Pain: 4 people, 7.02%
Osteoporosis (bones weak and more likely to break): 3 people, 5.26%
Partial Seizures (seizures which affect only a part of the brain at onset): 2 people, 3.51%
Depression: 2 people, 3.51%
Idiopathic Generalised Epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis): 2 people, 3.51%
Upper Respiratory Tract Infection: 1 person, 1.75%
Encephalitis Autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain): 1 person, 1.75%

* Approximation only. Some reports may have incomplete information.

Do you take Perampanel and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Perampanel:

Perampanel (2,474 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Perampanel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,222 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,471 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on perampanel (the active ingredients of Perampanel) and Perampanel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.